Click a link below to view the mailing archive as if it had been sent to you.
| 2024-04-30 12:15 | | Eli Lilly’s growth drivers, Verzenio and Jardiance, suffer clinical setbacks and more... |
| 2024-04-30 00:15 | | FDA finalizes lab developed test rule over industry opposition and more... |
| 2024-04-29 12:15 | | Repertoire pivot pays dividends with Bristol Myers deal and more... |
| 2024-04-29 00:15 | | 'The Top Line': A look at pharma revenue rankings and more... |
| 2024-04-26 12:15 | | Why the obesity drug market is about to get a lot more crowded and more... |
| 2024-04-26 00:15 | | European Commission approves Astellas’ drug for expanded prostate cancer Treatment and more... |
| 2024-04-25 12:15 | | BMS to cut 2,200 jobs in $1.5B restructuring as Opdivo sales drop in Q1 and more... |
| 2024-04-25 00:15 | | Biogen: Don’t expect any big acquisitions this year and more... |
| 2024-04-24 12:15 | | About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows and more... |
| 2024-04-24 00:15 | | Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem and more... |
| 2024-04-23 12:15 | | Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint and more... |
| 2024-04-23 00:15 | | Bristol Myers taps startup to boost cell therapy production and more... |
| 2024-04-22 12:15 | | AbbVie tops doctor ranking of immunology companies, handily beating Pfizer and J&J and more... |
| 2024-04-22 00:15 | | AAN 2024: Pharma Two B’s P2B001 shows promise in early PD and more... |
| 2024-04-19 12:15 | | Roche wins FDA OK for targeted drug in early lung cancer and more... |
| 2024-04-19 00:15 | | FDA mandates label updates on CAR-T cancer therapies and more... |
| 2024-04-18 12:15 | | AI Identifies New Potential Treatments For Parkinson’s Disease and more... |
| 2024-04-18 00:15 | | IGM and Sanofi collaboration will pivot to immunology and inflammation and more... |
| 2024-04-17 12:15 | | Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus and more... |
| 2024-04-17 00:15 | | Biotech naming trends bypass 'buzzwords and business speak' to build whimsical, memorable brands and more... |
| 2024-04-16 12:15 | | J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales and more... |
| 2024-04-16 00:15 | | Pfizer, BioNTech win pause in patent infringement case from rival Moderna and more... |
| 2024-04-15 12:15 | | 5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra and more... |
| 2024-04-15 00:15 | | Rinvoq reclaims top Rx, OTC pharma brand crown and more... |
| 2024-04-12 12:15 | | Vaccines, next-gen approaches target the toughest cancers: AACR and more... |
| 2024-04-12 00:15 | | Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff and more... |
| 2024-04-11 12:15 | | Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader and more... |
| 2024-04-11 00:15 | | Vertex to buy kidney disease drugmaker Alpine for $4.9B and more... |
| 2024-04-10 12:15 | | The IRA Is Already Curtailing Small Molecule Drug Development. Here’s How to Reverse That. and more... |
| 2024-04-10 00:15 | | Psychiatry drugs finally have pharma’s attention. Can they keep it? and more... |
| 2024-04-09 12:15 | | 5 Successful Phase III Oncology Trials in Q1 and more... |
| 2024-04-09 00:15 | | Women want to participate in clinical trials. Lack of flexibility is still a problem. and more... |
| 2024-04-08 12:15 | | The Next Wave of ADCs Could Treat Evasive Solid Tumors and more... |
| 2024-04-08 00:15 | | FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers and more... |
| 2024-04-05 12:15 | | J&J scoops up cardio medtech Shockwave Medical for $13.1B and more... |
| 2024-04-04 12:15 | | Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail and more... |
| 2024-04-04 00:15 | | Parkinson’s disease may be helped by GLP-1 drug, new study finds and more... |
| 2024-04-03 12:15 | | Genmab leans into hot ADC space with $1.8B ProfoundBio acquisition and more... |
| 2024-04-03 00:15 | | Top 5 medical marketing trends for 2024 and more... |
| 2024-04-02 12:15 | | J&J targets rare maternal-fetal diseases: 'We're going for this. No one else has.' and more... |
| 2024-04-02 00:15 | | Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study and more... |
| 2024-04-01 12:15 | | BMS Pulls Ahead of Amgen, Aces Confirmatory Phase III NSCLC Trial for Krazati and more... |
